Publication | Closed Access
Liver resectability of advanced liver-limited colorectal liver metastases following mFOLFOX6 with bevacizumab (KSCC0802 Study).
21
Citations
26
References
2014
Year
mFOLFOX6 with bevacizumab regimen is safe and effective for advanced liver-limited CRLM and might lead to high liver resectability.
| Year | Citations | |
|---|---|---|
Page 1
Page 1